SCHEMBL3670519

SCHEMBL3670519

O=S(=O)(Nc1ccccc1)c1cccnc1I

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
GAA P10253 2/20 0.48
TP53 P04637 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
IL1RN P18510 1/20 0.47
KEAP1 Q14145 1/20 0.47
ERAP1 Q9NZ08 1/20 0.47
DUSP3 P51452 1/20 0.47
PTPN5 P54829 1/20 0.47
CASP6 P55212 1/20 0.47
PTPN11 Q06124 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
TET2 Q6N021 1/20 0.46
HTT P42858 1/20 0.45
PKM P14618 2/20 0.44
GRM4 Q14833 1/20 0.43
SLC40A1 Q9NP59 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9959446 0.81 ALDH1A1 (0.56) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL27973531 0.80 ACLY (0.55) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL7627388 0.78 KEAP1 (0.67) ALDH1A1MEN1KMT2AIL1RNKEAP1
SCHEMBL3768663 0.77 KEAP1 (0.55) ALDH1A1MEN1KMT2AIL1RNKEAP1
SCHEMBL8171482 0.77 KEAP1 (0.47) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL9954267 0.76 SLC22A12 (0.55) KDM4EALDH1A1MEN1KMT2ATP53
SCHEMBL18862467 0.76 KDM4E (0.60) KDM4EALDH1A1MEN1KMT2AGAA
SCHEMBL10288795 0.75 TET2 (0.51) ALDH1A1IL1RNKEAP1ERAP1TET2
SCHEMBL6431253 0.74 KEAP1 (0.57) KDM4EALDH1A1MEN1KMT2AIL1RN
SCHEMBL2579130 0.73 KDM4E (0.50) KDM4EALDH1A1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
EP-2155703-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Inhibox Ltd. (GB) 2010-02-24 EP disclosed
WO-2008142376-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS INHIBOX LTD. (GB) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents TNF, CS, COASY KDM4E 3812/4885ALDH1A1 1941/4885MEN1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.